Four Seasons Parkway Run & Walk Raises Over $1 Million
Oct 13, 2015
The Four Seasons Parkway Run & Walk raised over $1 million and proceeds support research and survivorship programs at CHOP’s Cancer Center.
The transport team includes nurses, medics, emergency medical technicians (EMTs), respiratory therapists, physicians, intake clinicians, equipment techs and communication specialists. Each team member has a different skill set and plays a vital role.
Oct 13, 2015
The Four Seasons Parkway Run & Walk raised over $1 million and proceeds support research and survivorship programs at CHOP’s Cancer Center.
Oct 6, 2015
CHOP celebrated the grand opening of a 44,000-square-foot Specialty Care and Ambulatory Surgery Center in Glen Mills, Pa. that will bring additional services to local families.
Oct 5, 2015
On Oct. 4, CHOP's Center for Fetal Diagnosis and Treatment hosted a reunion at the Cleveland Botanical Gardens for families across the Midwest who traveled to CHOP for fetal surgery or specialized care immediately after birth.
Oct 1, 2015
A new study in animals shows very dynamic ways in which the immune system responds to influenza virus, and may offer insights for designing better vaccines.
Sep 30, 2015
CHOP researchers have debunked the claim that childhood vaccinations may cause young children to have retinal hemorrhage (bleeding in the eye’s retina).
Sep 25, 2015
Mitchondria, the tiny structures that are power plants of our cells, may have helped humans and other mammals adapt and evolve over the eons.
Sep 13, 2023
An attending physician in the Division of Infectious Diseases at Children's Hospital of Philadelphia clears up common misconceptions about the flu shot.
Sep 17, 2015
New NIH funding supports CHOP research in genetic causes of childhood conditions, returning this information to families and improving treatments.
Sep 16, 2015
A research team led by a CHOP eye surgeon suggests that routine retinal screening of children with type 1 diabetes can begin later than current guidelines recommend.
Sep 10, 2015
Building on its decades-long investigations in the biology and treatment of neuroblastoma, CHOP will lead the consortium’s neuroblastoma research program.